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Abstract
Purpose Studies on broccoli (Brassica oleracea var. italica) indicate beneficial effects against a range of chronic diseases, 
commonly attributed to their bioactive phytochemicals. Sulforaphane, the bioactive form of glucoraphanin, is formed by 
the action of the indigenous enzyme myrosinase. This study explored the role that digestion and cooking practices play in 
bioactivity and bioavailability, especially the rarely considered dose delivered to the colon.
Methods The antimicrobial activity of sulforaphane extracts from raw, cooked broccoli and cooked broccoli plus mustard 
seeds (as a source myrosinase) was assessed. The persistence of broccoli phytochemicals in the upper gastrointestinal tract 
was analysed in the ileal fluid of 11 ileostomates fed, in a cross-over design, broccoli soup prepared with and without mus-
tard seeds.
Results The raw broccoli had no antimicrobial activity, except against Bacillus cereus, but cooked broccoli (with and without 
mustard seeds) showed considerable antimicrobial activity against various tested pathogens. The recovery of sulforaphane 
in ileal fluids post soup consumption was < 1% but the addition of mustard seeds increased colon-available sulforaphane 
sixfold. However, when sulforaphane was extracted from the ileal fluid with the highest sulforaphane content and tested 
against Escherichia coli K12, no inhibitory effects were observed. Analysis of glucosinolates composition in ileal fluids 
revealed noticeable inter-individual differences, with six “responding” participants showing increases in glucosinolates after 
broccoli soup consumption.
Conclusions Sulforaphane-rich broccoli extracts caused potent antimicrobial effects in vitro, and the consumption of sul-
foraphane-enriched broccoli soup may inhibit bacterial growth in the stomach and upper small intestine, but not in the 
terminal ileum or the colon.
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Introduction
Broccoli (Brassica oleracea var. italica) is a member of 
the Brassicaceae family of plants. Epidemiological stud-
ies, dietary trials, animal and in vitro investigations have 
revealed a range of potential beneficial effects of broc-
coli on a range of chronic diseases such as different types 
of cancers [1–4] and cardiovascular diseases [5–7]. The 
beneficial effects are commonly attributed to bioactive 
phytochemicals present that includes hydroxycinnamic 
acids, flavonoids (e.g., quercetin, kaempferol, myricetin), 
carotenoids (lutein) and glucosinolates (e.g., glucorapha-
nin) [8–10].
Glucosinolates are of great interest; in broccoli gluc-
oraphanin is present in the highest quantity, comprising 
about 80% of the total, with smaller amounts of gluco-
brassicin, 4-methoxyglucobrassicin and 1-methoxygluco-
brassicin also being found [11]. The biologically active 
forms of the glucosinolates are isothiocyanates which are 
generated by the action of the enzyme myrosinase that is 
released when the plant tissue is chopped or chewed [12]. 
In the case of glucoraphanin, the isothiocyanate formed 
is sulforaphane, less bioactive nitriles can also be formed 
by the activity of epithiospecifier protein (ESP) [13]. Sul-
foraphane has been shown in vitro to exert bioactivity 
[14–18] and to exert antibacterial effects against a range 
of food-borne pathogens and enteropathogenic microbes 
including Listeria monocytogenes, Escherichia coli, Sal-
monella Typhimurium and Helicobacter pylori [9, 19–21].
The effect of cooking Brassica vegetables on the 
absorption of isothiocyanates has been well studied [12]. It 
was reported that only 3.4% of sulforaphane was recovered 
in blood and urine after consuming microwaved broccoli 
due to myrosinase inactivation [22]. Similarly, isothiocy-
anates levels were three-fold higher in urine after con-
sumption of raw broccoli compared with steamed broccoli 
(32.3% vs 10.2%) [23]. Fahey et al. [24] also demonstrated 
that active myrosinase was critical to the bioavailability of 
glucoraphanin in broccoli extracts as sulforaphane was 3–4 
times more bioavailable in extracts with an active myrosi-
nase enzyme than in extracts without. Similarly, Ghawi 
et al. [25] reported that the addition of mustard seeds, 
which contain a more resilient isoform of myrosinase, to 
heat-processed broccoli increased the formation of sul-
foraphane by 3–5fold.
In terms of bioavailability, Johnson [26] reported that 
isothiocyanates were absorbed through the small bowel 
and colon, where their metabolites were detected 2–3 h 
post consumption, with Petri and colleagues in an elegant 
study showing high levels of absorption for sulforaphane 
and quercetin 3,4’-diglucoside from an onion and broccoli 
extract by enterocytes using a perfused jejunal segment 
and determined that a proportion was effluxed back into 
the lumen as sulforaphane-glutathione and quercetin-
3’-glucuronide [27]. An often-neglected aspect, however, 
is the role that digestion and cooking practices play in 
bioactivity and bioavailability, especially in relation to 
amounts of phytochemicals delivered to the colon.
In the present study, we have used ‘Beneforté broccoli’, a 
new variety that contains enhanced levels of glucoraphanin 
[28], which previous studies have demonstrated a threefold 
greater increase in the concentration of plasma sulforaphane 
compared to standard broccoli [29]. The aim of this study 
was two-fold: firstly to establish the antimicrobial activity of 
sulforaphane extracts from raw, cooked broccoli and cooked 
broccoli with a mustard seed (to provide myrosinase activ-
ity), and secondly to determine the persistence of broccoli 
phytochemicals and their metabolites in the upper gastroin-
testinal tract by analyzing the ileal output from ileostomates 
fed with a broccoli soup prepared with or without mustard 
seeds.
Materials and methods
Broccoli powder preparation and thermal 
processing
Beneforté broccoli was supplied by Staples Vegetables 
Ltd. (Boston, Lincolnshire, UK); mustard seeds (MS) were 
sourced from a local supermarket. Broccoli heads were cut 
(around 4–5 cm from top) and combined thoroughly. For the 
cooking experiments, 50 g portions were vacuum-packed in 
flexible polyethylene bags with dimensions of 24 × 24 cm, to 
stop glucoraphanin leaching into the processing water. Using 
a thermostatic water bath, broccoli was cooked at 100 °C for 
12 min. Mustard seeds were ground and added as a powder. 
All samples of raw and cooked broccoli were frozen in dry 
ice before storage at −80 °C; following this, samples were 
lyophilized (VirTis SP Scientific, UK), ground using a coffee 
grinder and sieved (30 mesh). Samples were finally stored 
at −20 °C until further analysis. The solids content of fresh 
broccoli was 11.9% (w/w).
Preparation of broccoli soup for the intervention 
study
The broccoli powder was prepared in the pilot plant facili-
ties at the Department of Food and Nutritional Sciences at 
the University of Reading. All other ingredients were pur-
chased from local stores at reading, uk. soup preparation was 
conducted at the pilot plant facilities. Good manufacturing 
practices (GMP) and hazard analysis critical control point 
(HACCP) were implemented throughout the preparation 
process to ensure the safety of the products. Ingredients to 
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prepare the soup for the intervention study were shipped to 
Ulster University. Soup was locally prepared fresh prior to 
consumption. In brief, ingredients (Supplementary material 
1), except broccoli powder and mustard seed powder, were 
dissolved in 50 ml cold water, and then added to 11 g broc-
coli powder in 150 ml boiling water. The resulting soup was 
then left to boil for 3 additional min to inactivate ESP [13]. 
The soup was left to cool down to 60 °C, and then mustard 
seed powder was added. The soup was allowed to stand for 
10 min before it was served. Thirty-six untrained panellists 
were recruited to participate in a consumer evaluation test to 
determine the soup palatability at different broccoli powder 
concentrations (Supplementary material 2).
Extraction and analysis of glucoraphanin 
from broccoli powder
Extraction of glucoraphanin from the broccoli samples was 
conducted as described previously by Oerlemans et al. [30] 
with minor modifications. Glucotropaeolin (0.25 ml of 1 mg/
ml) (Santa Cruz Biotechnology, Heidelberg, Germany) was 
used as an internal standard. Freeze-dried samples (0.2 g) 
were extracted three times with 70% methanol at 70 °C for 
10 min; these conditions were selected to inactivate myrosi-
nase and avoid hydrolysis of the glucosinolates. Samples 
were centrifuged (3500g, 5 min), supernatants were com-
bined and filtered (0.45 µm syringe filter) and finally topped 
up to 10 ml using 70% methanol. The extract was then puri-
fied using a mini column (HiTrap DEAE FF anion exchange 
column, 1 ml) (GE Healthcare, Chalfont, UK). Briefly, the 
column was washed five times with deionised water (1 ml 
each), and then 1 ml of the crude extract was passed through 
the column. The column was washed from unbound com-
pounds with deionized water (2 × 1 ml) and sodium acetate 
buffer (2 × 1 ml; 20 mM, pH 5.0). Sulfatase enzyme (75 µl, 
35 mg/ml) (Type H-1 from Helix pomatia, Sigma, Poole, 
UK) was added, and the column was incubated overnight 
at room temperature. The desulfo-glucosinolates were then 
eluted from the column using deionised water (4 × 1 ml). 
The eluate was dried using a rotary evaporator (70 °C) 
and re-dissolved in 0.5 ml of deionised water. The purified 
extract was filtered (0.45 µm syringe filter) and injected 
onto the HPLC. The desulfo-glucosinolates analysis was 
conducted with an HPLC–UV system (Agilent 1200, Man-
chester, UK) using an ACE 5 C18 reverse-phase column 
(150 × 4.6 mm) (Hichrom) with a flow rate of 1 ml/ min; 
absorbance measurement was conducted at a wavelength of 
229 nm. The mobile phase was (A) water and (B) 20% ace-
tonitrile. The following gradient was used: 100% (A) and 0% 
(B) for 1 min, B increased up to 100% over 20 min, returning 
to 100% (A) over 5 min and holding at 100% (A) for 4 min. 
The column temperature was set at 30 °C and the injection 
volume was 10 µl. Glucoraphanin quantification was carried 
out using desulfo-glucoraphanin as an external standard. All 
glucosinolate standards were sourced from Santa Cruz Bio-
technology, Heidelberg, Germany. Organic solvents (HPLC-
grade) were from Fisher Scientific (Loughborough, UK).
Extraction and GC–MS analysis of sulforaphane 
and sulforaphane nitrile from broccoli powder
Extraction of sulforaphane and its nitrile analogue (sul-
foraphane nitrile) from broccoli samples was conducted 
as described by Ghawi et  al. [25] with some modifica-
tions. 0.5 g of lyophilised broccoli powder was placed in 
a tube with 10 ml deionized water and incubated for 1 h at 
30 °C. These conditions were selected to ensure complete 
hydrolysis of glucosinolates by myrosinase. Samples were 
centrifuged (5000g, 5 min) and the supernatant was col-
lected; this step was repeated twice, and the supernatants 
were combined. To extract isothiocyanates and the nitrile 
analogues from the supernatant, 10 ml of dichloromethane 
were added to 10 ml of supernatant in a glass tube, vortexed 
for 1 min and centrifuged (5000g for 5 min); then the organic 
phase was collected. The extraction process was repeated 
two more times and the extracts were combined. About 3 g 
of unhydrated sodium sulphate were added to the extract to 
remove any excess water. The extract was then dried using 
a rotary evaporator (30 °C) and the eluate was re-dissolved 
in 0.7 ml dichloromethane and filtered using 0.22 µm filter.
The extracts were analyzed using GC–MS for sul-
foraphane and sulforaphane nitrile. GC–MS was performed 
using an Agilent 7850/5975 GC–MS system (Agilent, UK). 
The samples (1 µl) were injected onto a ZB-AAA capil-
lary column (Phenomenex, USA) (0.25 µm film thickness, 
15 m × 0.25 mm i.d.). The injection temperature was 250 °C 
and the split mode 1:20. The oven temperature was pro-
grammed from 110 to 320 °C at a rate of 30 °C/min. The 
flow rate of the helium carrier gas was 1.1 ml/min and the 
transfer line temperature held at 320 °C. Mass spectra were 
obtained by electron ionisation at 70 eV, and the mass scan 
was from 35 to 500 amu. Quantification of sulforaphane 
and sulforaphane nitrile was based on sulforaphane exter-
nal standard.
Extraction and HPLC analysis of sulforaphane 
from the soup and ileal fluids
Sulforaphane was extracted from broccoli soup based on 
the methodology described by Ghawi et al. [25]. One ml 
of the soup was centrifuged at 5000g, and the supernatant 
was collected; the pellet was extracted twice using 10 ml 
distilled water, and the supernatants were combined. Sul-
foraphane was extracted from the supernatant using 10 ml 
of dichloromethane for 1 min; the extraction step was car-
ried out twice. The organic layers were collected (about 
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15 ml) and ~ 4 g sodium phosphate was added to remove 
any remaining water. Dichloromethane was evaporated using 
a rotary evaporator, and the pellet was dissolved in 0.6 ml of 
acetonitrile and filtered using a 0.45 µm filter.
Sulforaphane was extracted from ileal fluid samples as 
follows: 15 ml of the ileal fluid was centrifuged (14,500g, 
10 min, 10 °C) and the supernatant was collected. The pel-
let was re-extracted with 10 ml water, and the supernatants 
were then combined. Sulforaphane was extracted from the 
supernatant using dichloromethane and treated as described 
above.
Ten microlitres of the filtrate were injected in an 
HPLC–UV system (Agilent 1200, Manchester, UK) using an 
ACE 5 C18 reverse-phase column (150 × 4.6 mm) (Hichrom) 
with a flow rate of 1 ml/min. The mobile phase was (A) 
water and (B) 100% acetonitrile. The following gradient 
was used: 100% (A) and 0% (B) for 1 min, B increased up 
to 100% over 20 min, returning to 100% (A) over 5 min 
and holding at 100% (A) for 4 min. The column tempera-
ture was set at 30 °C, whereas the absorbance was meas-
ured at 254 nm. Serial dilutions of sulforaphane standards 
(10–1600 µg/ml) were used to construct the standard curve. 
Organic solvents (HPLC-grade) were from Fisher Scientific 
(Loughborough, UK).
For comparison of sulforaphane concentrations by both 
GC and LC methods, the mean of each data set was used 
for statistical analysis. The Shapiro–Wilk test was used to 
test for normality and the Mann Whitney U test was used 
to compare groups. Significance was accepted at p < 0.05 
unless otherwise specified. Analysis was carried out using 
SPSS (version 25 for Windows).
Assessment of antimicrobial activity 
of sulforaphane extracts from broccoli powder
The bacteria used to test the antimicrobial activity of broc-
coli sulforaphane extracts included strains of the genera Sal-
monella, Escherichia, Staphylococcus, Listeria and Bacil-
lus. Information on each strain and its origin is provided 
in Supplementary material 3. To understand the impact of 
broccoli sulforaphane extracts on food or in the gut, all bac-
terial strains with the exception of E. coli K12 used in these 
experiments are gram-positive and -negative foodborne 
pathogens. E. coli K12 is the most commonly used strain in 
microbiological research [31] and its use facilitated further 
genetic research we conducted on the antibacterial mode of 
action of broccoli sulforaphane extracts. We also included 
the pathogenic E. coli O157:H7-VT strain which although 
it is unable to produce verotoxin, it shares all other features 
with pathogenic strains. To get an insight on the antimicro-
bial mechanism of broccoli sulforaphane extracts we also 
included two S. Typhimurium strains, one with an intact 
and the other with defective RpoS. RpoS is the main stress 
gene regulator in Salmonella enterica and the majority of 
gram-negative bacteria [32]. We also included a pathogenic 
L. monocytogenes strain originally isolated from the human 
disease [33] with its isogenic mutant in glutamate decar-
boxylase gadD2 that plays a role in antimicrobial resistance 
[34]. All bacterial strains were stored in 30% glycerol at 
−80 °C. The cells were cultured on nutrient agar (Oxoid) for 
up to 2 days, then three single colonies were obtained and 
transferred into 2 ml of phosphate buffer saline (PBS) solu-
tion. The turbidity of the suspensions was adjusted to match 
approximately a 0.5 McFarland standard (Fisher Scientific). 
The antimicrobial activity was tested using the disc diffusion 
method as described by Aires et al. [19]. In brief, from a 
bacterial suspension, a sterile cotton swab was spread onto 
Petri dishes (90 mm diameter) containing 20 ml of Muel-
ler–Hinton Agar (Oxoid). Sterile filter paper discs (6 mm 
diameter; Oxoid) were impregnated with 100 µl of extracted 
sulforaphane samples and then placed on the agar plate; 
the plates were incubated in an inverted position overnight 
at 37 °C. The equivalent volume of solvent (acetonitrile) 
without sulforaphane extract was used as a negative control. 
Antibiotics, namely chloramphenicol (30 µg/ml), ampicillin 
(10 µg/ml), gentamicin (10 µg/ml) and tetracycline (30 µg/
ml) (Oxoid) were used as positive controls. After overnight 
incubation, the diameter of the inhibitory zones around the 
disc was measured and recorded. All tests were performed 
in triplicate and the antibacterial activity was expressed as 
the mean of the diameters (in mm) of the inhibition zones. 
T test was used to compare the means of antibacterial activ-
ity, means were considered statistically different if p < 0.05 
(Excel, Microsoft Office 365 ProPlus).
To determine the lowest concentration of sulforaphane 
needed to exert an antimicrobial effect, the minimum inhibi-
tion concentration (MIC) assay was conducted in a 96-well 
plate, as described by Wiegand et al. [35] using E. coli K12 
as the indicator microorganism. Briefly, the 96 well plate 
was loaded with 150 µl of nutrient broth inoculated with 
 107 CFU/ml of an overnight E. coli K12 culture (cell con-
centration of overnight culture ~ 109 CFU/ml). Immediately 
after the addition of the culture, 150 µl of 2 mg/ml sul-
foraphane (LKT Laboratories, USA) were added in the first 
well, and then serial dilutions were made to achieve a range 
1–0.03 mg/ml of sulforaphane. The plate was incubated at 
37 °C in a micro-plate reader for 24 h and the optical density 
measured at 620 nm and plotted over time. The experiment 
was performed in triplicate for each dilution.
Dietary intervention study with ileostomy patients
The use of ileostomy patients combined with metabolomics 
can provide insight into the processes of biotransforma-
tion and absorption in the upper gastrointestinal tract that 
impact the phytochemicals in the ingested plant material, 
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in the case of broccoli glucoraphanin and sulforaphane, 
potentially influencing bioactivity and health benefits [36, 
37]. The ileostomy feeding study, an acute randomised, sin-
gle-blind, placebo-controlled crossover study with 1-week 
washout, used a soup prepared (described earlier) from Ben-
eforté broccoli, a hybrid of Brassica oleracea and Brassica 
villosa [28], supplied by Staples Vegetables Ltd (Boston, 
Lincolnshire, UK) and mustard seeds were sourced from a 
local supermarket (ASDA, Reading, UK). Soup was chosen 
as the intervention food product to ensure that the partici-
pants received a homogenous and uniform food providing a 
consistent quantity of broccoli phytochemicals delivered in 
the form of a powdered broccoli-based soup. Thereby mini-
mising the impact of any interplant composition variation 
and ensuring that effects observed biologically were a con-
sequence of inter-person variation in ADME alone. As no 
studies existed on broccoli consumption and ileostomists, a 
4-h post-consumption sampling point selected to ensure cap-
ture of the appearance of phytochemicals from the interven-
tion food. This choice was consistent with ileostomy studies 
that used a liquid-based vehicle to deliver phytochemicals 
and showed substantive quantities to be evident in ileal fluid 
after 4 h [38, 39]. While a one week washout period for the 
study was considered appropriate as it ensured that broccoli 
phytochemicals would have passed through the gastrointes-
tinal tract after consumption of a single bolus meal (soup, 
200 ml).
Ethical approval (14/SC/1326) for the study was received 
from the South Central-Hampshire Research Ethics Com-
mittee and Ulster University. All participants gave written 
informed consent and the study was conducted in accordance 
with the Helsinki Declaration. Participants were recruited 
between Jan 2015 and Feb 2015 from clinics at Altnagelvin 
Hospital. The intervention study ran between March 2015 
and April 2015. The study was registered at clinicaltrials.
gov as NCT04113928. The study was conducted in 11 ileos-
tomists (7 males, 4 females) age range 32–63 years, who had 
undergone terminal ileostomies and were at least 1.5 years 
post-operative prior to the study and were non-smokers.
After obtaining consent, participants were randomly 
assigned, in blocks of four using a random-number genera-
tor (www.rando mizat ion.com), to either the intervention or 
the control. In total, 12 participants were randomised to 2 
groups. One participant subsequently withdrew from the 
study prior to sampling. Participants were asked to follow 
a restriction diet, avoiding dark green leafy vegetable and 
mustard-like vegetables especially broccoli, cabbage, Brus-
sels sprouts, watercress, rocket, spinach, onions, spring 
onions, radish, horseradish for 48 h before each clinic visit. 
Following an overnight fast, the participants provided an 
ileal fluid sample (T 0 h) then consumed 200 ml of freshly 
prepared broccoli soup (described above) with/without the 
addition of mustard seed, within 15 min, a second ileal fluid 
sample was collected 4 h post consumption (T 4 h). The ileal 
fluid samples were collected and processed as described in 
McDougall et al. [40]. Weights and pH of the ileal fluid 
were recorded, before dilution with ice-cold distilled water 
as required, dependent on viscosity, before being homog-
enised in a chilled Waring blender for 30 s, and storage of 
aliquots at −80 °C in preparation for subsequent analysis.
Targeted analysis of glucosinolates in ileal fluids
Ileal fluids were extracted using the procedure outlined pre-
viously [40]. Briefly, frozen ileal fluid samples were thawed 
and vortex-mixed, and duplicate 2.0 ± 0.1 g samples were 
weighed into 15 ml centrifuge tubes. These were extracted 
using 3 ml of ultrapure water containing aqueous 0.1% for-
mic acid and 20 mM diethyl dithiocarbamate (DDC). The 
tubes were vortex-mixed for 3 × 30 s, then sonicated in a 
water bath for 1 min. All procedures were carried out at 5 °C. 
After centrifugation (2500g, 10 min, 5 °C), the supernatants 
were transferred to new tubes. The pellets were extracted 
twice using 3 ml of 0.1% formic acid in methanol containing 
20 mM DDC, and the supernatants combined and vortex-
mixed. A subsample of 4 mL was removed and dried in a 
Speed-Vac. The dried samples were resuspended in 0.5 mL 
of 10% (v/v) acetonitrile containing 500 µM morin as an 
internal standard then transferred into filter vials (Thomson, 
0.45 μM PTFE filter vial: Bioprocess Engineering Services 
Ltd., Ashford, Kent, UK). The samples were analysed by 
liquid chromatography-mass spectrometry (LC–MS) using 
an Agilent 1260 Infinity HPLC 6230 time of flight (TOF) 
mass spectrometry system operated under MassHunter (Agi-
lent, Ltd. UK) software. The TOF/MS system was tuned 
and calibrated according to the manufacturers recommended 
procedures for use across 80–2000 m/z in negative mode. 
Sub 3 ppm mass accuracies were achieved by applying the 
recommended reference mass locking solution to a second-
ary ESI probe via a secondary HPLC pump at a flow rate of 
2.5 mL/min with 1:100 splitter (25 μL/min to source) using 
the m/z values at 112.985587 and 1033.988109 in the nega-
tive mode as standard reference locks. The method for quan-
tification of Gls is given in the Supplementary material 4.
Data handling and statistical analysis 
for non‑targeted analysis
The LC–MS raw data were converted into MZML centroid 
format using the Proteowizard MSConvert software pack-
age (https ://prote owiza rd.sourc eforg e.net/). The data was 
then deconvoluted using the XCMS online package (https ://
xcmso nline .scrip ps.edu/) producing a Microsoft Excel-based 
XY matrix of the paired RT and m/z of each feature against 
the peak intensity for each sample. The dataset was next 
subjected to automated peak annotation workflows within 
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PutMedID [41, 42] which grouped m/z features likely associ-
ated with the same compound (i.e., a ‘peak group’). Accu-
rate mass differences between m/z within each peak group 
were next calculated to allow the annotation of the parent 
m/z, isotope and adduct ions, as well as common in-source 
fragments. The neutral accurate mass was then matched to 
libraries of possible metabolites (Plant Metabolic Network 
PlantCyc database (https ://www.plant cyc.org/ and the Man-
chester Metabolomics Database (MMD: https ://dbkgr oup.
org/MMD/). After annotation, non-grouped low intensity 
features, redundant isotope, adduct and fragment features 
were removed from the dataset to reduce data complexity. 
Principal components analysis and optimized partial least 
squares-discriminant analysis was applied to the XCMS data 
to identify components that increased in the after broccoli 
ileal fluids. Full details are given in Supplementary mate-
rial 5.
Antimicrobial activity of sulforaphane extracted 
from ileostomy fluids against Escherichia coli K12
To assess the antimicrobial activity, sulforaphane was 
extracted from ileostomy fluid in a similar way to that from 
soup, with the exception that the final pellet was dissolved 
in 0.6 ml nutrient broth (Oxoid) instead of acetonitrile. The 
concentration of sulforaphane in nutrient broth was 3.14 µM. 
A 96-well plate titration method was used to assess the 
inhibitory effect of extracted sulforaphane against E. coli 
K12 cells. The sulforaphane containing nutrient broth was 
filtered through a 0.20 µm filter, and 200 µl were dropped 
into each well. E. coli K12 grown overnight in nutrient broth 
at 37 °C was used as inoculum. Each well was inoculated 
with an impregnate needle, and the plates were incubated 
at 37 °C for 24 h; the absorbance was measured at 620 nm 
using a plate reader (Sunrise™, Tecan, Austria). The 
obtained growth curves were compared with that of the con-
trol (no sulforaphane addition) in terms of their lag phase, 
growth curve pattern and final optical density to evaluate the 
effect of antimicrobial effect of sulforaphane.
Results
Quantification of glucoraphanin, sulforaphane 
and sulforaphane nitrile in broccoli samples
The glucoraphanin content in raw broccoli was 10.68 µmol/g 
broccoli powder and cooking did not significantly reduce 
content (9.97 µmol/g) (Fig. 1). Sulforaphane was low in 
raw broccoli (0.57 µmol/g DW) with significantly higher 
levels of sulforaphane nitrile (9.9 µmol/g DW). Cooking of 
broccoli did not increase the concentration of sulforaphane 
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Fig. 1  Glucoraphanin, sulforaphane and sulforaphane nitrile contents in raw, cooked (100 °C for 12 min) broccoli, and cooked broccoli after the 
addition of mustard seed powder (MS)
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(0.58 µmol/g DW) compared to raw (Fig. 1), probably as 
cooking inactivated the endogenous myrosinase activ-
ity. However, the addition of mustard seed powder (2%) 
to cooked broccoli significantly (P < 0.05) increased sul-
foraphane formation from 0.58 to 10.90  µmol/g DW. 
Although sulforaphane nitrile level increased after the 
addition of mustard seeds (0.05 vs 0.69 μmol/g DW), this 
increase is low compared to the level formed in broccoli 
before cooking (0.69 vs 9.9 µmol/g DW).
Sulforaphane content in broccoli soups
Following the initial studies, a broccoli soup was prepared 
which contained 26.5 µmol of sulforaphane per 200 ml por-
tion (0.13 µmol/ml soup). The addition of 2% mustard seed 
powder at the cooling stage of the soup preparation process 
(~ 60 °C) increased the level of sulforaphane by nearly four-
fold in the soup, 102 µmol per 200 ml portion (0.51 µmol/
ml soup).
Antimicrobial activities of broccoli sulforaphane 
extracts
The raw broccoli extracts showed no antimicrobial activity 
(Table 1), except against B. cereus. In contrast, the extracts 
from cooked broccoli (with and without mustard seeds) 
showed considerable antimicrobial activity against the tested 
strains. Furthermore, the extracts from cooked broccoli with 
added mustard seed exhibited significantly higher activity 
(T test; p < 0.05) than the cooked broccoli without MS. This 
increased activity could be interpreted as being due to the 
increased levels of isothiocyanate, mainly sulforaphane 
(Fig. 1), formed from glucoraphanin (~ 81% of total glu-
cosinolate content in broccoli [11]), presumably due to the 
activity of myrosinase from the MS. Other compounds such 
as allyl isothiocyanate originating from MS may contribute 
to the antimicrobial activity, however, this contribution is 
likely to be minor as MS was added in very small quantity to 
broccoli (2%). The greatest zone of inhibition was reported 
for B. cereus (13.7–46.7 mm). Lower antimicrobial activities 
were generally observed for the gram-positive bacteria such 
as S. aureus and L. monocytogenes strains compared to the 
gram-negative ones such as S. enterica, and E. coli.
Interestingly, all cooked broccoli extracts demonstrated a 
strong inhibitory effect against both the antibiotic-resistant 
S. Typhimurium str.10 and str.30 (inhibition zones ranging 
from 10 to 25 mm; Table 1). With E. coli and S. Typhimu-
rium strains, the cooked broccoli with MS extracts were as 
effective as gentamycin. The cooked broccoli extracts also 
demonstrated an inhibitory effect on L. monocytogenes 
Table 1  Inhibition zones (in mm) from disc diffusion method assessing the antimicrobial activity of sulforaphane-rich dichloromethane extracts 
from raw, cooked and cooked (plus mustard seed) broccoli and of different antibiotics against various bacterial strains
*Indicates a statistically significant difference (p < 0.05) between inhibition zones with raw broccoli and cooked broccoli. **Indicates a statisti-
cally significant difference (p < 0.05) between inhibition zones with cooked broccoli and cooked broccoli with mustard seeds. Statistically sig-
nificant difference was assessed with the use of T test
Bacterial stain Raw broccoli Cooked broccoli Cooked broccoli 
plus mustard seed
Chloram-
phenicol 
(30 µg/ml)
Ampicillin (10 µg/
ml)
Gentamicin 
(10 µg/ml)
Tetra-
cycline 
(30 µg/
ml)
Mean (mm) ± SD, n = 3
S. Typhimurium 
DT104 str. 10
ND 15.3 ± 0.6 * 23.3 ± 0.6 ** ND 0.0 ± 0.0 18.0 ± 0.0 9.0 ± 0.0
S. Typhimurium 
DT104 str.30
ND 15.3 ± 0.6 * 22.3 ± 0.6 ** 29.0 ± 0.0 26.5 ± 0.7 18.5 ± 0.7 27.5 ± 0.7
S. Hadar ND 15.0 ± 1.0 * 20.7 ± 0.6 ** 27.0 ± 0.0 26.5 ± 0.7 17.0 ± 0.0 ND
S. Virchow ND 15.7 ± 0.6 * 25.0 ± 0.0 ** 27.5 ± 0.7 27.5 ± 0.7 19.0 ± 0.0 28.0 ± 0.0
S. Heidelberg ND 14.7 ± 0.6 * 21.7 ± 0.6 ** 26.5 ± 0.7 26.0 ± 0 19.0 ± 0.0 27.5 ± 0.7
S. Anatum ND 15.3 ± 0.6 * 23.0 ± 0.0 ** 24.0 ± 1.4 21.0 ± 0 16.5 ± 0.7 25.5 ± 0.7
E. coli K12 ND 14.7 ± 0.6 * 23.3 ± 0.6 ** 29.5 ± 0.7 ND 22.0 ± 0.0 31.0 ± 0.0
E. coli O157:H7-
VT
ND 14.3 ± 0.6 * 20.3 ± 0.6 ** 30.0 ± 0.0 ND 20.5 ± 0.7 30.5 ± 0.7
S. aureus 408 ND 12.7 ± 0.6 * 18.3 ± 0.6 ** 35.0 ± 0.0 24.5 ± 0.7 32.0 ± 0.0 42.5 ± 0.7
B. cereus 138 19 ± 1.0 34.7 ± 0.6 * 45.3 ± 0.6 ** NA NA NA NA
L. monocytogenes 
10403S WT
ND 10.3 ± 0.6 * 18.3 ± 0.6 ** 25.0 ± 0.0 21.5 ± 0.7 23.0 ± 0 31.5 ± 0.7
L. monocytogenes 
10403S ∆gadD2
ND 10.3 ± 0.6 * 18.0 ± 0.0 ** 25.5 ± 0.7 22.0 ± 0 25.0 ± 0 32.5 ± 0.7
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(inhibition zones ranging from 10 to 18 mm). The minimum 
inhibitory concentration (MIC, the concentration at which 
cell growth was completely inhibited) for pure sulforaphane 
against E. coli K12 was established at 1 mg/ml (5.65 mM), 
(Supplementary material 6), with concentrations as low as 
0.03 mg/ml exerting some inhibition of bacterial growth.
Ileostomy feeding study with broccoli soup
Eleven ileostomates (males n = 7, females n = 4) were 
enrolled on this acute randomised, single-blind, placebo-
controlled two-way crossover trial. The intervention was 
conducted as per the protocol and with the consent of par-
ticipants, all 11 subjects completed the study and there were 
no adverse events associated with the consumption of broc-
coli soup (Fig. 2). The study population had a mean group 
age of 53.3. ± 9.2 years. The average weight of ileal fluid 
day 1 (0 h) 233 g ± 84, pH 5.9 ± 0.7, day 2 214 g ± 84, pH 
5.9 ± 0.6.
The group mean content of sulforaphane in the ileal 
fluids from subjects given broccoli without mustard seeds 
was 0.17 µmol, with considerable inter-individual variation 
(Table 2). This represents a recovery of < 1% of the applied 
sulforaphane in the original soup. The addition of MS to the 
broccoli soup significantly increased the group mean amount 
of sulforaphane in the ileal fluids to 1.05 µmol (a six-fold 
increase), once again with a substantial inter-individual vari-
ation. This is a significant increase in colonic availability of 
sulforaphane.
Glucosinolates (GIs) content and composition were quan-
tified in ileal fluids before and after broccoli soup intake 
using targeted LC–MS TOF analysis against individual glu-
cosinolate standards. There were considerable inter-individ-
ual differences in response; only six of the eleven subjects 
(SUBJs 1, 7, 8, 10, 11 and 12) showed clear increases in 
GIs after soup intake (Fig. 3) and there was considerable 
variation in the composition and levels of GIs between the 
responders. The five “non-responding” subjects either had 
high levels of GIs in pre-intervention samples (SUBJs 2, 
5 and 6) or showed very low levels of GIs in any samples 
Fig. 2  Consort diagram, progress of participants through the intervention study
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(SUBJs 4 and 9). The GIs composition in the ileal fluids 
from the responders had glucoraphanin as the dominant 
component but there was considerable variation in the com-
position of other GIs between the responding subjects. In 
SUBJs 10 and 12, Gls content was more pronounced in the 
broccoli soup without mustard seeds. This is expected as 
myrosinase in broccoli was inactivated during soup prepara-
tion. However, the same pattern does not hold for the other 
responders.
In addition, a non-targeted approach was applied to iden-
tify components that also increased in ileal fluids following 
broccoli soup intake. The MS data were deconvoluted using 
XCMS software and multivariate statistical analyses (Prin-
cipal Component and OPLS-DA analysis) were employed to 
identify components that increased after soup intake (Sup-
plementary material 7, Figs. 1, 2, 3, 4). As expected, the 
non-targeted analysis of the responders also identified the 
presence of the same GIs in the ileal fluids (Supplementary 
material 8), confirming the targeted analysis. Allyl isothiocy-
anate (m/z 98; predicted formula  C4H5NS) was also detected, 
which could arise from the mustard seeds as a breakdown 
product of sinigrin [43].
However, other components were putatively identified 
which most probably arise from the broccoli consumed. 
The phenolic compound, feruloyl-sinapoyl-gentiobiose 
(m/z 723; predicted formula  C33H40O18), is characteristic 
of broccoli florets (https ://foodb .ca/compo unds/FDB00 
2177) but can be found in other Brassicas. Kaempferol 
sophoroside (m/z 609,  C27H30O16) was also identified 
and this is known to be a major phenolic component of 
broccoli (https ://pheno l-explo rer.eu/conte nts/food/263). 
Feruloyl putrescine was also identified and this has been 
confirmed in other studies on broccoli [44]. A component 
with m/z 163 (predicted formula  C9H8O3) was also identi-
fied which could be phenylpyruvate. The absence of other 
more abundant broccoli phenolics (as detailed in https ://
pheno l-explo rer.eu/conte nts/food/263) probably reflects 
their relative stability in the gut.
Antimicrobial effect of sulforaphane extracted 
from ileostomy fluid against E. coli K12
Following analysis of the ileal samples (Fig. 2), subject 
S04 was identified as having the highest amounts of sul-
foraphane at 3.14 µmol (equivalent to 41 µM) and was 
selected as a candidate to assess inhibitory effect against 
E. coli K12. It was not possible to carry out anti-microbial 
assessment using the ileal fluid per se, given the inherent 
presence of small intestinal microbiota, consequently sul-
foraphane was extracted from the ileal fluid, dried, and re-
constituted to the original ileal fluid concentration (41 µM) 
in nutrient broth to evaluate its antimicrobial activity 
against E. coli K12. The results indicated no difference 
in the growth of E. coli in the presence of sulforaphane 
compared to the control (data not shown). The MIC of 
pure sulforaphane against E. coli K12 was 5.65 mM (1 mg/
ml) but 171 µM (0.03 mg/ml) exerted some inhibition of 
bacterial cell growth.
Table 2  Sulforaphane content in 
all ileal fluids post consumption 
(4 h)
Data as group means (n = 11) were assessed for normality and compared by Mann Whitney U test, 
*p = 0.007
Broccoli soup without mustard seeds Broccoli soup with mustard seeds
Sulforaphane (SF) per soup portion (200 ml)
SF = 26 ± 0.01 µmol
Sulforaphane (SF) per soup portion 
(200 ml)
SF = 102.2 ± 0.03 µmol
Subject no Total SF (µmol) Recovery (%) Total SF (µmol) Recovery (%)
S01 0.00 0.00 0.49 0.48
s02 0.00 0.00 3.21 3.15
s04 0.36 1.38 3.14 3.08
s05 0.48 1.83 0.00 0.00
S06 0.26 1.01 0.26 0.26
S07 0.00 0.00 1.88 1.84
s08 0.26 1.00 0.42 0.41
S09 0.33 1.26 0.66 0.65
S10 0.00 0.00 0.10 0.10
s11 0.07 0.27 0.94 0.92
s12 0.11 0.42 0.49 0.48
Group mean 0.17 ± 0.17 0.65 1.05* ± 0.66 1.03
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Discussion
Studies on broccoli (Brassica oleracea var. italica) indi-
cate beneficial effects against a range of chronic diseases, 
commonly attributed to their bioactive phytochemicals. Sul-
foraphane, the bioactive form of glucoraphanin, is formed 
by the action of the enzyme myrosinase. This study explored 
the role that digestion and cooking practices play in bioactiv-
ity and bioavailability, especially the rarely considered dose 
delivered to the colon.
The processing of the broccoli from raw to the cooked 
forms with and without the added enzyme myrosinase, in the 
form of mustard seeds, altered the phytochemical composi-
tion of the various broccoli powders (Fig. 1). Cooking broc-
coli did not significantly reduce the glucoraphanin content 
and indeed only limited glucosinolate thermal degradation 
has been noted at processing temperatures lower than 110 °C 
[30, 45]. Consequently, the cooking process likely denatured 
broccoli’s endogenous thermo-labile myrosinase preventing 
hydrolysis of the glucosinolates. Sulforaphane was low in 
raw broccoli but higher levels of sulforaphane nitrile were 
present, which agrees with previous literature [46–48]. The 
formation of sulforaphane nitrile rather than sulforaphane in 
raw broccoli is due to the action of epithiospecifier protein 
Fig. 3  GIucosinolates contents in ileal samples before and after 
broccoli soups, subjects 1, 7, 8,10, 11, and 12. GI Glucoiberin, SIN 
sinigrin, GN gluconapin, GE glucoerucin, GB glucobrassicin, Gna 
gluconasturtiin, GR glucoraphanin, GA glucoalysin, HGB hydroxy-
glucobrassicin, NGB neoglucobrassicin, MGB neoglucobrassicin
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(ESP), a non-catalytic cofactor of myrosinase that promotes 
the formation of epithionitriles from alkenyl glucosinolates. 
The formation of sulforaphane nitrile was substantially 
reduced after cooking which indicates that ESP, the highly 
temperature-sensitive protein [45], was inactivated during 
cooking. The addition of mustard seeds powder (2%) to 
cooked broccoli soup significantly increased sulforaphane 
formation (fourfold) while sulforaphane nitrile was detected 
at low levels. Therefore, the addition of low concentrations 
of mustard seeds powder, which contains a thermally resist-
ant myrosinase [45, 49], to cooked broccoli has the potential 
to intensify sulforaphane formation.
The in  vitro antimicrobial activities of broccoli sul-
foraphane extracts were in line with the results from previ-
ous studies which have shown that pure sulforaphane has 
a broad antimicrobial spectrum effect against both gram-
negative and gram-positive bacteria [19, 20, 50–53]. How-
ever, the present study showed that gram-negative bacteria, 
such as E. coli and S. enterica were more susceptible to 
sulforaphane than gram-positive bacteria, such as L. mono-
cytogenes and S. aureus, with the exception of the gram-
positive B. cereus. In this study, we used two highly similar 
S. Typhimurium DT104 strains (strains 10 and 30). Strain 
30 possesses a fully functional RpoS, whilst strain 10 pos-
sesses a defective RpoS due to an amber non-sense codon 
[32]. RpoS is the main stress gene regulator in S. enterica 
and other gram-negative bacteria involved in resistance to 
a variety of stresses [32]. Interestingly, both strains were 
equally susceptible to broccoli extracts suggesting that RpoS 
and its regulon that comprises hundreds of stress genes may 
not play a role in resistance against broccoli extracts or 
sulforaphane. We also included a mutant in the glutamate 
decarboxylase gene gadD2 in L. monocytogenes which plays 
a role in antimicrobial resistance, did not show a different 
behaviour comparing to the wild type E. coli K12 suggest-
ing that also this gene does not play a role in resistance to 
broccoli extracts or sulforaphane.
Bacteria, such as E. coli O157: H7, S. Typhimurium 
DT104 and L. monocytogenes, which were tested in this 
study are associated with gastrointestinal infections and 
food poisoning and can cause considerable health problems 
to humans. For instance, E. coli O157:H7 can cause acute 
haemorrhagic diarrhoea [54]. Enterotoxigenic E. coli can 
colonize the upper bowel and cause watery diarrhoea which 
in some cases can lead to death [55], and S. Typhimurium 
DT104 can also cause diarrhoea, fever, headache, nausea, 
abdominal pain and vomiting. L. monocytogenes is another 
important potentially pathogenic bacterium which can cause 
listeriosis through the colonisation of the gastrointestinal 
tract, which is one of the deadliest foodborne infections in 
the Developed World [56]. While the antimicrobial activ-
ity of the broccoli extracts was comparable to ampicillin, 
chloramphenicol, tetracycline and gentamycin (Table 1). It 
should be stated that this comparison is not based on weight 
since antibiotics are normally used in low quantities. How-
ever, this comparison is valid since the concentrations of 
antibiotics and broccoli used in these experiments are com-
parable to the levels that would be found in the intestinal 
tract following ingestion of broccoli and that in an infection 
site following administration of these antibiotics. Overall, 
the results obtained from this study, suggest that cooked 
broccoli extracts might be promising natural agents for con-
trolling human pathogens during the gastrointestinal diges-
tion of foods, with the addition of myrosinase potentiating 
the antimicrobial activity possibly due to the enhanced level 
of sulforaphane. Considered from the in vivo perspective, 
following consumption of the broccoli soup(s) the ileal 
recovery of sulforaphane was < 1% which indicates early 
absorption in the small intestine consistent with observa-
tions by Petri et al. [27] who reported ~ 74% absorption of 
sulforaphane in a perfused jejunum section and highlighted 
that a proportion was conjugated to sulforaphane-glutathione 
and excreted back into the lumen and, therefore, low colonic-
availability. However, the addition of MS to the broccoli 
soup significantly increased the amount of sulforaphane 
available to the colon by sixfold, although there were con-
siderable inter-individual differences in responses evident. 
Similarly, a study in healthy participants reported that con-
sumption of broccoli (200 g) with brown mustard seeds 
increased urinary excretion of the sulforaphane metabolite 
sulforaphane N-acetyl-l-cysteine fourfold [57]. Sulforaphane 
extracted from the ileal fluid of subject S04 (which had the 
highest sulforaphane content) did not show antimicrobial 
activity against E. coli K12 presumably as the sulforaphane 
concentration was below the observed MIC (Supplementary 
material 6).
The targeted and non-targeted LC–MS approaches 
adopted in the study identified the presence of the expected 
GIs in the ileal fluids. Other compounds were also identified 
in the non-targeted approach including B-vitamins such as 
pantothenamide (m/z 217,  C9H18N2O4) and metabolites of 
biotin (vitamin B7), norbiotin (m/z 229,  C9H14N2O3S), bis-
norbiotin (m/z 215,  C8H12N2O3S) and biotin sulfoxide (m/z 
259,  C10H16N2O4S). Broccoli has a low content of biotin so 
these metabolites probably arise from the cheese and milk 
powder in the soup mix (Table in Supplementary material 
1). Pantothenamide is a food additive used as a precursor 
for pantothenic acid (vitamin B5) and probably also arises 
from these other soup ingredients. There are many puta-
tive peptides in the post-soup ileal fluids. Whilst one of 
these (e.g., Leu-Leu; leucyl-leucine; m/z 243,  C12H24N2O3) 
has been identified in broccoli previously [44], the others 
could arise from the digestion of proteins in the cheese and/
or sauce powder used in the formulation of the soups. It 
is intriguing that these components from the more prosaic 
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soup components are identified as soup-specific by the non-
targeted LCMS approach.
Other components were putatively identified as drugs, 
which may be a consequence of the skewed nature of the 
available databases towards pharmaceuticals, but some 
components may be more relevant. For example, colestipol 
(m/z 302,  C11H28ClN5O) is a bile acid sequestrant often 
prescribed for ileostomy patients (https ://bnf.nice.org.uk/
drug/coles tipol -hydro chlor ide.html). Napsagatran (m/z 597; 
 C26H36N6O7S) was putatively identified but it is unknown if 
this drug was prescribed to the subjects. We can only assume 
that these drugs have been taken with or before the soups 
and appear increased due to transit through the gut with the 
food bolus.
We also attempted to assess the antimicrobial effect of 
sulforaphane extracted from ileostomy fluid against E. coli 
K12, however, it was determined that even the broccoli soup 
modified to increase sulforaphane could not deliver sufficient 
concentrations to the terminal portion of the ileum to exert 
antimicrobial effects colonically. However, the higher con-
centration of sulforaphane in the broccoli soup with added 
myrosinase would be within the inhibitory range deter-
mined, so it is possible that this broccoli soup could inhibit 
the growth of bacteria present in the stomach and upper 
small intestine rather than the lower intestine. Also, the GIs 
present in the ileal fluids (Fig. 3) represent reservoirs of 
sulforaphane (i.e., from the major component, glucorapha-
nin, or other isothiocyanates from other GIs) that could be 
released by the colonic microflora [26]. Bacteria that could 
be potentially affected by sulforaphane include Helicobacter 
pylori, a pathogenic bacterium associated with gastric and 
duodenal ulcers, which has been suggested through human 
trials to be inhibited by sulforaphane [58–61].
To conclude, sulforaphane-enriched extracts from ben-
eforté broccoli exerted anti-microbial activity against gut 
pathogens in vitro and the inclusion of a heat-tolerant source 
of myrosinase in cooked broccoli can increase intestinal 
delivery of sulforaphane, albeit to very low levels.
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